Navigation

  • Skip to Content
NTNU Home

ntnu.edu

  • Studies
    • Master's programmes in English
    • For exchange students
    • PhD opportunities
    • All programmes of study
    • Courses
    • Financing
    • Language requirements
    • Application process
    • Academic calendar
    • FAQ
  • Research and innovation
    • NTNU research
    • Research excellence
    • Strategic research areas
    • Innovation resources
    • PhD opportunities
  • Life and housing
    • Student in Trondheim
    • Student in Gjøvik
    • Student in Ålesund
    • For researchers
    • Life and housing
  • About NTNU
    • Contact us
    • Faculties and departments
    • Libraries
    • International researcher support
    • Vacancies
    • About NTNU
    • Maps
  1. Employees

Språkvelger

Norsk

Benjamin Brigant

Benjamin Brigant

Postdoctoral Fellow
Department of Clinical and Molecular Medicine

benjamin.brigant@ntnu.no
+4773598479 Kunnskapssenteret, Øya
About

About

I completed my PhD in June 2019 at the Jules Verne University of Picardy (France) where I was supervised by both Prof. Laurent Metzinger and Prof. Jacques Rochette. During my PhD, I studied the role of E3 ubiquitin ligase TRIM37 in chondrocytes and involvement of miR-223 in control of TRIM37 function.  

Following my PhD, I joined the lab of Prof. Basil Hubbard at the University of Alberta (Canada) to complete my first Postdoc. Prof. Hubbard is an expert in development of gene editing technologies and other macromolecular therapeutics. I thus considerably expanded my repertoire of experimental techniques to include CRISPR Cas13 methodology to control gene function. I also contributed to the global effort to combat COVID-19 by screening for drugs against NSP15 protein that used an innovative gene reporter assay to screen a 100,000 molecules library. Such high throughput searches for novel therapeutics provided me with new competence in drugs screening using small molecule libraries (publication in preparation).  

 I reached out to Dr. Victor Boyartchuk at NTNU’s Centre of Molecular Inflammation Research, a Centre of Excellence funded by the Research Council of Norway. Since OA intersects chondrocyte function and inflammatory biology, I wished to work with Dr. Boyartchuk, an expert in Inflammation and immunology to address this question to complement his ongoing studies. I joined his team in November 2020 and have since developed a range of new model lines deficient for TRIM37 and CD5L in macrophages and chondrocytes. Our preliminary data demonstrate the major role of these 2 proteins in cartilage (publication in preparation). 

NTNU
Studies
  • Master's programmes in English
  • For exchange students
  • PhD opportunities
  • Courses
  • Career development
  • Continuing education
  • Application process
Contact
  • Contact NTNU
  • Employees
  • For alumni
  • Press contacts
  • Researcher support
Discover NTNU
  • Experts
  • Vacancies
  • Pictures from NTNU
  • Innovation resources
  • NTNU in Gjøvik
  • NTNU in Trondheim
  • NTNU in Ålesund
  • Maps
About NTNU
  • NTNU's strategy
  • Research excellence
  • Strategic research areas
  • Organizational chart
  • Libraries
  • About the university
Services
  • For employees
  • For students
  • Blackboard
  • Intranet

Norwegian University of Science and Technology

Use of cookies
Accessibility statement (in Norwegian)
Privacy policy
Editorial responsibility
Sign In